Skip to main
University-wide Navigation

College of Pharmacy Adds New Faculty During 2022-2023 Academic Year

The University of Kentucky College of Pharmacy (UKCOP) welcomed two additional junior faculty to the Pharmacy Science and Practice, and Pharmaceutical Sciences departments, during the 2022-2023 academic year.

Pharmacy’s Dean honored with Portoghese Lectureship Award

R. Kip Guy, Ph.D., dean of the University of Kentucky College of Pharmacy (UKCOP), has been named the recipient of the 2022 Philip S. Portoghese Medicinal Chemistry Lectureship Award. This award from the American Chemical Society (ACS) and the Journal of Medicinal Chemistry honors Guy for his outstanding contributions to medicinal chemistry.

Dwoskin to Receive National Award for Innovation

Dr. Linda Dwoskin has been named the recipient of the 2022 Innovator Award by the College on Problems of Drug Dependence.

Alex Flannery and David Feola Receive Inaugural Clinical Research Catalysts Pilot Award

Alex Flannery (PharmD, PhD) and David Feola (PharmD, PhD) recently received the $50,000 University of Kentucky College of Pharmacy’s Inaugural Clinical Research Catalysts Pilot Award for their research project “Urinary Immune Cell Profiling in Sepsis-Associated Acute Kidney Injury.”

Jill Turner Awarded Neuropharmacology Early Career Award

Jill Turner, a University of Kentucky College of Pharmacy assistant professor was recently awarded the American Society for Pharmacology and Experimental Therapeutics (ASPET) Neuropharmacology Early Career Award for 2021.

UKCOP Researchers Discuss the Potential Benefit of Azithromycin in Fighting COVID-19 Related Inflammation

Drs. Vince Venditto and David Feola have been studying the immunomodulatory effects of the antimicrobial drug azithromycin in the context of diseases in which inflammation drives part of the pathology including pneumonia, spinal cord injury, and heart attack.

UK Pharmacist Part of Committee to Better Serve Patients with Heart Conditions

According to the Centers for Disease Control and Prevention (CDC), in the United States more than 450,000 people are hospitalized each year due to a condition called atrial fibrillation, or AFib. AFib can cause chest pains, shortness of breath, irregular heartbeat, and ultimately increases the risk of stroke. While there are a variety of treatments for AFib, the American College of Cardiology Oversight Committee recently published an updated medication decision pathway for management of anticoagulation for AFib, venous thromboembolism (VTE), and other heart conditions.

UKCOP Researchers Receive $3M in Funding to Develop Treatments to Combat Ewing Sarcoma

A group of University of Kentucky College of Pharmacy researchers received $3 million in NIH funding to develop new treatments to combat the rare cancer Ewing sarcoma. Because cancer research is such a massive field spanning across different disciplines, UKCOP researchers decided to utilize team science to approach the project.

UK Grad Student Receives NIH F31 Award for a project started with UK IRC pilot funding

UK College of Pharmacy graduate student Kaitlind Howard received a competitive grant from the National Institutes of Health for a project that previously received pilot funding from the UK Igniting Research Collaborations program.

Prisinzano Named New Director of UK’s Center for Pharmaceutical Research and Innovation

Thomas Prisinzano, Ph.D., professor in the Department of Pharmaceutical Sciences, has been named director of the Center for Pharmaceutical Research and Innovation (CPRI). Prisinzano replaces former Director Jon Thorson, who was recently promoted to associate dean of research in the University of Kentucky College of Pharmacy.

We wish to remember and honor those who inhabited this Commonwealth before the arrival of the Europeans. Briefly occupying these lands were the Osage, Wyndott tribe, and Miami peoples. The Adena and Hopewell peoples, who are recognized by the naming of the time period in which they resided here, were here more permanently. Some of their mounds remain in the Lexington area, including at UK’s Adena Park.

In more recent years, the Cherokee occupied southeast Kentucky, the Yuchi southwest Kentucky, the Chickasaw extreme western Kentucky and the Shawnee central Kentucky including what is now the city of Lexington. The Shawnee left when colonization pushed through the Appalachian Mountains. Lower Shawnee Town ceremonial grounds are still visible in Greenup County.

We honor the first inhabitants who were here, respect their culture, and acknowledge the presence of their descendants who are here today in all walks of life including fellow pharmacists and healthcare professionals.